We are live on ! Find out more
LVAC

LAVA Medtech Acquisition Corp. Class A Common Stock

Delisted

LVAC was delisted on the 10th of May, 2023.

18 hedge funds and large institutions have $45.1M invested in LAVA Medtech Acquisition Corp. Class A Common Stock in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
+18
Holders Change %
% of All Funds
0.28%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
Reduced
Closed
Calls
$197K
Puts
Net Calls
+$197K
Net Calls Change
+$197K

LVAC Hedge Fund Activity: Q4 2021 in Review

18 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) for Q4 2021, worth a combined $45.1M.

Buyers outnumbered sellers: 18 funds opened new LVAC positions and 0 closed out — a net gain of 18 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Beryl Capital Management, opening a new position worth an estimated $9.89M.

  • 18 institutional investors held LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) as of Q4 2021, up from 0 in Q3 2021.
  • Funds reported $45.1M of LAVA Medtech Acquisition Corp. Class A Common Stock stock for Q4 2021.
  • 18 funds opened new LAVA Medtech Acquisition Corp. Class A Common Stock positions in Q4 2021 and 0 closed out, a net change of +18 holders.
  • The largest LAVA Medtech Acquisition Corp. Class A Common Stock buyer in Q4 2021 was Beryl Capital Management, an estimated $9.89M added.

Based on aggregated 13F filings for Q4 2021.